{"doi":"10.1136/jitc-2024-010179","title":"Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer","abstract":"BACKGROUND: Breast cancer (BC) continues to be a major health concern with 250,000 new cases diagnosed annually in the USA, 75% of which are hormone receptor positive (HR+), expressing estrogen receptor alpha (ER) and/or the progesterone receptor (PR). Although ER-targeted therapies are available, 30% of patients will develop resistance, underscoring the need for new non-ER/estrogen-based treatments. Notably, HR+BCs exhibit poor lymphocyte infiltration and contain an immunosuppressive microenvironment, which contributes to the limited efficacy of immunotherapies in HR+BC. In this study, we demonstrate that PR/progesterone signaling reduces major histocompatibility complex (MHC) Class I expression, facilitating immune evasion and escape from immune-based clearance of PR+tumors. METHODS: To determine the effect of PR/progesterone on MHC Class I expression, we treated human and mouse mammary tumor cell lines with progesterone and/or interferon (IFN) and measured expression of genes involved in antigen processing and presentation (APP), as well as surface MHC Class I expression. We used the OT-I/SIINFEKL model antigen system to measure the impact of progesterone on immune cell-mediated killing of modified tumor cells. We also analyzed two large BC clinical cohorts to determine how PR expression correlates with APP gene expression and MHC Class I expression in ER-positive tumors. RESULTS: In vitro, we show that PR/progesterone signaling reduces APP gene expression and MHC class I expression in human and breast mammary tumor cell lines. PR-mediated attenuation of APP/MHC Class I expression is more pronounced in the presence of IFN. In immune cell killing assays, PR-expressing mammary tumor cells treated with progesterone are protected from immune-mediated cytotoxicity. We demonstrate that PR expression in vivo prevents immune-mediated rejection of xenoantigen-modified mammary tumor cell lines through mechanisms involving MHC Class I expression and CD8 T cells. Data analysis of two large BC cohorts reveals lower APP gene expression and MHC Class I expression in ER/PR-positive tumors compared with ER-positive/PR-negative tumors. These findings show that HR+BCs, specifically PR+tumors, downregulate APP/MHC class I machinery through PR/progesterone signaling. Use of pharmacological PR/progesterone inhibitors may reverse these effects in patients with BC, thereby improving immunosurveillance and response to immunotherapies.","journal":"Journal for ImmunoTherapy of Cancer","year":2025,"id":518067,"datarank":0.32958368660043297,"base_score":2.1972245773362196,"endowment":2.1972245773362196,"self_citation_contribution":0.32958368660043297,"citation_network_contribution":0.0,"self_endowment_contribution":0.32958368660043297,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":8,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9585,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1049182,"name":"Harmony Saunders","orcid":null,"position":1,"is_corresponding":false},{"id":695696,"name":"Lauryn R. Werner","orcid":"0000-0003-3876-2556","position":2,"is_corresponding":false},{"id":640396,"name":"Xiaopeng Sun","orcid":"0009-0009-5219-8964","position":3,"is_corresponding":false},{"id":1315957,"name":"Eilidh I Chowanec","orcid":"0000-0002-3319-0256","position":4,"is_corresponding":false},{"id":570727,"name":"Amanda Heard","orcid":"0000-0002-7150-7998","position":5,"is_corresponding":false},{"id":487859,"name":"Prabhakar Chalise","orcid":"0000-0001-5581-1220","position":6,"is_corresponding":false},{"id":307386,"name":"Jeffery M. Vahrenkamp","orcid":"0000-0002-2937-1513","position":7,"is_corresponding":false},{"id":1167853,"name":"Andrea Wilson","orcid":"0000-0002-9773-6975","position":8,"is_corresponding":false},{"id":403701,"name":"Cong-Xiao Liu","orcid":null,"position":9,"is_corresponding":false},{"id":402946,"name":"Gangjun Lei","orcid":"0000-0002-0505-0475","position":10,"is_corresponding":false},{"id":402944,"name":"Jun-Ping Wei","orcid":"0000-0001-6311-6033","position":11,"is_corresponding":false},{"id":1385495,"name":"Hugo Cros","orcid":null,"position":12,"is_corresponding":false},{"id":380852,"name":"Hisham Mohammed","orcid":"0000-0003-0275-9793","position":13,"is_corresponding":false},{"id":270126,"name":"Melissa A. Troester","orcid":"0000-0001-9506-6624","position":14,"is_corresponding":false},{"id":1883,"name":"Charles M. Perou","orcid":"0000-0001-9827-2247","position":15,"is_corresponding":false},{"id":471534,"name":"Mary A. Markiewicz","orcid":"0000-0001-5685-8573","position":16,"is_corresponding":false},{"id":23865,"name":"Jason Gertz","orcid":"0000-0001-7568-6789","position":17,"is_corresponding":false},{"id":236816,"name":"Justin M. Balko","orcid":"0000-0002-4263-5974","position":18,"is_corresponding":false},{"id":402948,"name":"Zachary C. Hartman","orcid":"0000-0001-6549-8207","position":19,"is_corresponding":false},{"id":378170,"name":"Christy R. Hagan","orcid":"0000-0003-2524-1815","position":20,"is_corresponding":false},{"id":1385023,"name":"Julio C Tinoco","orcid":"0000-0001-9182-8695","position":0,"is_corresponding":true}],"reference_count":102,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:49:04.756302Z","pmid":"40102028","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}